CellResearch Therapeutics

Singapore, Singapore Founded: 2022 • Age: 4 yrs
Pioneers stem cell research for treatments of diabetic foot ulcers and hair loss conditions.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About CellResearch Therapeutics

CellResearch Therapeutics is a company based in Singapore (Singapore) founded in 2022. It operates as a B2B. CellResearch Therapeutics offers products and services including CorLicyte and CorLISome. CellResearch Therapeutics operates in a competitive market with competitors including BiomX, Cosmo Pharmaceuticals, Hope Medicine, Aurealis Therapeutics and Triple Hair, among others.

  • Headquarter Singapore, Singapore
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Cellresearch Therapeutics
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CellResearch Therapeutics

CellResearch Therapeutics offers a comprehensive portfolio of products and services, including CorLicyte and CorLISome.

Product name locked
Category locked
Primary

Treatment for diabetic foot ulcers using cord lining stem cells.

Product name locked
Category locked
Locked

Therapy platform for various chronic conditions via stem cell technology.

Funding Insights of CellResearch Therapeutics

Premium access

Detailed funding history for CellResearch Therapeutics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CellResearch Therapeutics

Investments
Premium access

Investment portfolio details for CellResearch Therapeutics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CellResearch Therapeutics

Premium access

Detailed financials for CellResearch Therapeutics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cellresearch Therapeutics Comparisons

CellResearch Therapeutics Primary company
Description
Pioneers stem cell research for treatments of diabetic foot ...
Location
Singapore, Singapore
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for CellResearch Therapeutics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CellResearch Therapeutics

CellResearch Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BiomX, Cosmo Pharmaceuticals, Hope Medicine, Aurealis Therapeutics and Triple Hair, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Microbiome therapeutics are developed for dysbiosis-linked diseases.
Locked Locked Locked
Therapeutics for gastrointestinal diseases are developed and provided.
Locked Locked Locked
Monoclonal antibodies are developed for treating multiple diseases.
Locked Locked Locked
Provider of cell & gene therapy platforms for chronic wounds, cancer, and inflammatory diseases
Locked Locked Locked
Developer of treatments for alopecia
Locked Locked Locked
Drug repurposing and discovery are enabled by a proprietary platform.
Premium access

Detailed competitors of CellResearch Therapeutics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cellresearch Therapeutics

Premium access

Complete news archive for CellResearch Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CellResearch Therapeutics

CellResearch Therapeutics was founded in 2022.

CellResearch Therapeutics is headquartered in Singapore, Singapore.

CellResearch Therapeutics is a biotechnology company that specializes in umbilical cord lining stem cells for developing treatments. It focuses on conditions like diabetic foot ulcers, androgenic alopecia, and other chronic diseases through research and clinical trials. The company collaborates with scientists and operates from Singapore, announcing positive phase 1 results and partnerships to advance cellular therapies.

CellResearch Therapeutics's top competitors include BiomX, Cosmo Pharmaceuticals and Hope Medicine.

CellResearch Therapeutics offers CorLicyte and CorLISome.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available